Archive

Green light for 12 new medicines from EU watchdog

Written by | 8 Apr 2024

The European Medicines Agency (EMA) has recommended the approval of twelve new products, following reviews by its key human medicines committee (CHMP). This brings to twenty-five the number […]

EU recommendations for seasonal flu vaccine composition

Written by | 7 Apr 2024

The winter flu season may be over in the northern hemisphere, but EU regulators are already looking ahead to the next outbreak in autumn 2024. Influenza viruses continuously […]

EU gives green light for 7 new medicines

Written by | 23 Oct 2023

The European Medicines Agency (EMA) has recommended seven medicines for approval at its October 2023 meeting. The brings the total number of newly approved medicines this year to […]

EU drug watchdog warns of fake Ozempic pens

Written by | 22 Oct 2023

The European Medicines Agency (EMA) is warning patients and healthcare professionals to beware of pre-filled pens falsely labelled as Ozempic, a diabetes medicine linked to weight loss. National […]

First RSV vaccine to protect infants and older adults

Written by | 7 Sep 2023

EU medicines regulators have approved a vaccine to protect against disease caused by the respiratory syncytial virus (RSV). Abrysvo is the first RSV vaccine indicated for passive immunisation […]

Green light for two new medicines in the EU

Written by | 22 Jun 2023

The European Medicines Agency (EMA) has approved two new medicines at its May meeting. This brings to 30, the number of products given the green light by the […]

Green light for new medicines in the EU

Written by | 13 Apr 2023

The European Medicines Agency (EMA) approved a total of 89 new medicines in 2022. Of these, 41 had a new active substance which had never been authorised in […]

Study finds “important shortcomings” in official cancer drug information

Written by | 10 Apr 2023

Important information about cancer drug benefits, and related uncertainties, is frequently omitted from official prescription drug information sources for clinicians and patients in Europe, finds an analysis published […]

Four new medicines approved by EMA

Written by | 4 Feb 2023

The European Medicines Agency (EMA) has approved four new medicines at its January meeting, getting 2023 off to a low-key start. The Agency’s key human medicines committee (CHMP) […]

EMA offers enhanced support to non-profit drug developers

Written by | 10 Oct 2022

The European Medicines Agency (EMA) has launched a pilot to support the translation of basic research developments into medicines that could make a difference in patients’ lives in […]

EU green light for 12 new medicines – including 5 orphan drugs

Written by | 8 Oct 2022

The European Medicines Agency (EMA) has approved 12 new medicines at the September meeting of its key decision-making panel, the Committee on Human Medicinal Products (CHMP). The expert […]

EU experts back second COVID-19 booster for vulnerable groups

Written by | 2 Aug 2022

The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) have recommended second booster doses of mRNA COVID-19 vaccines for people aged 60 […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.